To find the potential targets of USP1 in DLBCL, we first analyzed the proteins interacting with USP1 in the GEO database, and the results showed that the expression levels of MAX in DLBCL patient samples were significantly higher than those of healthy controls (Supplementary Fig. S3a). The gene discussed is USP1; the disease is diffuse large B-cell lymphoma.